Skip to main content

Advertisement

Log in

Holmium Laser Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: a Safe and Effective Treatment Option in our Elderly Patients

  • Urology (T Griebling, Section Editor)
  • Published:
Current Geriatrics Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Treatment of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH) can present a surgical dilemma for elderly patients, especially in those with multiple comorbidities. The purpose of this paper is to review recent publications on this topic and highlight the benefits of holmium laser enucleation of the prostate (HoLEP) in such patients.

Recent Findings

HoLEP is a safe and effective treatment option for patients with BPH of any age with any prostate size. It is superior to many other BPH treatment options. It can be safely completed in those on anticoagulants, in the re-treatment setting for recurrent symptoms, in those with concurrent prostate cancer, and in patients with various types of bladder dysfunction.

Summary

HoLEP is a safe and effective treatment option for elderly patients with BPH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Humphreys MR, Miller NL, Handa SE, Terry C, Munch LC, Lingeman JE. Holmium laser enucleation of the prostate-outcomes independent of prostate size. J Urol. 2008;180:2431–5. https://doi.org/10.1016/j.juro.2008.08.019.

    Article  PubMed  Google Scholar 

  2. Maserejian NN, Chen S, Chiu GR, Wager CG, Kupelian V, Araujo AB, et al. Incidence of lower urinary tract symptoms in a population-based study of men and women. Urology. 2013;82:560–4. https://doi.org/10.1016/j.urology.2013.05.009.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Litman HJ, McKinlay JB. The future magnitude of urological symptoms in the USA: projections using the Boston Area Community Health survey. BJU Int. 2007;100:820–5. https://doi.org/10.1111/j.1464-410X.2007.07018.

    Article  PubMed  Google Scholar 

  4. Foster HE, Barry MJ, Dahm P, Gandhi MC, Kaplan SA, Kohler TS, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol. 2018;200:612–9. https://doi.org/10.1016/j.juro.2018.05.048.

    Article  PubMed  Google Scholar 

  5. Gilling PJ, Cass CB, Cresswell MD, Fraundofer MR. Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology. 1996;47(1):48–51.

    Article  CAS  PubMed  Google Scholar 

  6. Fraundorfer MR, Gilling PJ. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol. 1998;33(1):69–72.

    Article  CAS  PubMed  Google Scholar 

  7. • Anderson B, Heiman J, Large T, Lingeman JE, Krambeck AE. Trends and perioperative outcomes across major BPH procedures form the ACS-NSQIP 2011-2015. J Endourol. 2019;33:62–8. https://doi.org/10.1089/end.2018.0266 This large study identified patients undergoing BPH procedures in the United States utilizing the NSQIP database. Utilization of HoLEP was constant during this timeframe. HoLEP was noted to have lower rates of re-operation, readmission, and urinary tract infection when compared to other procedures in some years.

    Article  PubMed  Google Scholar 

  8. van Rij S, Gilling PJ. In 2013, holmium laser enucleation of the prostate (HoLEP) may be the new ‘gold standard’. Curr Urol Rep. 2012;13(6):427–32. https://doi.org/10.1007/s11934-012-0279-4.

    Article  PubMed  Google Scholar 

  9. Yin L, Teng J, Huang CJ. Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol. 2013;27(5):604–11. https://doi.org/10.1089/end.2012.0505.

    Article  PubMed  Google Scholar 

  10. Fayad AS, Elsheikh MG, Zakaria T, Elfottoh HA, Alsergany R, Elshenoufy A, et al. Holmium laser enucleation of the prostate verus bipolar resection for the prostate: a prospective randomized study. “Pros and cons”. Urology. 2015;86(5):1037–41. https://doi.org/10.1016/j.urology.2015.08.004.

    Article  PubMed  Google Scholar 

  11. Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53:160–6. https://doi.org/10.1016/j.eururo.2007.08.036.

    Article  PubMed  Google Scholar 

  12. Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18 month follow-up of a randomized trial. J Endourol. 2004;18:189–91. https://doi.org/10.1089/089277904322959851.

    Article  PubMed  Google Scholar 

  13. Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up. Eur Urol. 2006;50:563–8. https://doi.org/10.1016/j.eururo.2006.04.003.

    Article  PubMed  Google Scholar 

  14. Moody JA, Lingeman JE. Holmium laser enucleation for prostate adenoma greater than 100 gm.: comparison to open prostatectomy. J Urol. 2001;165:459–62. https://doi.org/10.1097/00005392-200102000-00025.

    Article  CAS  PubMed  Google Scholar 

  15. Zhang MW, El Tayeb MM, Borofsky MS, Dauw CA, Wagner KR, Lowry PS, et al. Comparison of perioperative outcomes between holmium laser enucleation of the prostate and robotic-assisted simple prostatectomy. J Endourol. 2017;31:847–50. https://doi.org/10.1089/end.2017.0095.

    Article  PubMed  Google Scholar 

  16. Umari P, Fossati N, Gandaglia G, Pokorny M, De Groote R, Geurts N, et al. Robotic assisted simple prostatectomy versus holmium laser enucleation of the prostate for lower urinary tract symptoms in patients with large volume prostate: a comparative analysis from a high volume center. J Urol. 2017;197:1108–14. https://doi.org/10.1016/j.juro.2016.08.114.

    Article  PubMed  Google Scholar 

  17. Mmeje CO, Nunez-Nateras R, Warner JN, Humphreys Mitchell R. Age-stratified outcomes of holmium laser enucleation of the prostate. BJU Int. 2013;112(7):982–9. https://doi.org/10.1111/bju.12063.

    Article  PubMed  Google Scholar 

  18. • Piao S, Choo MS, Kim M, Jeon HJ, Oh SJ. Holmium laser enucleation of the prostate is safe for patients above 80 years: a prospective study. Int Neurourol J. 2016;20(2):143–50. https://doi.org/10.5213/inj.1630478.239 In this retrospective review of HoLEP perioperative outcomes stratified by patient age, octogenarians were noted to have increased hospital length of stay but other perioperative parameters were similar across all age groups.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bishop CV, Liddell H, Ischia J, Paul E, Appu S, Frydenberg M, et al. Holmium laser enucleation of the prostate: comparison of immediate postoperative outcomes in patients with and without antithrombotic therapy. Curr Urol. 2013;7:28–33. https://doi.org/10.1159/000343549.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Tyson MD, Lerner LB. Safety of holmium laser enucleation of the prostate in anticoagulated patients. J Endourol. 2009;23(8):1343–6. https://doi.org/10.1089/end.2009.0013.

    Article  PubMed  Google Scholar 

  21. • El Tayeb MM, Jacob JM, Bhojani N, Bammerlin E, Lingeman JE. Holmium laser enucleation of the prostate in patients requiring anticoagulation. J Endourol. 2016;30(7):805–9. https://doi.org/10.1089/end.2016.0070. In this retrospective cohort review, patients on anticoagulation required slightly longer duration of continuous bladder irrigation, but there was no difference in adverse events.

    Article  PubMed  Google Scholar 

  22. Rivera ME, Frank I, Viers BR, Rangel LJ, Krambeck AE. Holmium laser enucleation of the prostate and perioperative diagnosis of prostate cancer: an outcomes analysis. J Endourol. 2014;28:699–703. https://doi.org/10.1089/end.2014.0009.

    Article  PubMed  Google Scholar 

  23. Elkoushy MA, Elshal AM, Elhilali MM. Incidental prostate cancer diagnosis during holmium laser enucleation: assessment of predictors, survival, and disease progression. Urology. 2015;86:552–7. https://doi.org/10.1016/j.urology.2015.06.002.

    Article  PubMed  Google Scholar 

  24. Bhojani N, Boris RS, Monn MF, Mandeville JA, Lingeman JE. Coexisting prostate cancer found at the time of holmium laser enucleation of the prostate for benign prostatic hyperplasia: predicting its presence and grade in analyzed tissue. J Endourol. 2015;29:41–6. https://doi.org/10.1089/end.2014.0359.

    Article  PubMed  Google Scholar 

  25. Ohwaki K, Endo F, Shimbo M, Fujisaki A, Hattori K. Comorbidities as predictors of incidental prostate cancer after holmium laser enucleation of the prostate: diabetes and high-risk cancer. Aging Male. 2017;20:257–60. https://doi.org/10.1080/13685538.2017.1301417.

    Article  CAS  PubMed  Google Scholar 

  26. • Rosenhammer B, Lausenmeyer EM, Mayr R, Burger M, Eichelberg C. Holmium laser enucleation of the prostate provides similar incidental prostate cancer detection rates as open prostatectomy: a matched pair analysis. Urol Int. 2018;101:382–6. https://doi.org/10.1159/000492923 This study noted no difference in incidental prostate cancer detection in HoLEP vs open prostatectomy.

    Article  PubMed  Google Scholar 

  27. Capogrosso P, Capitanio U, Vertosick EA, Ventimiglia E, Chierigo F, Oreggia D, et al. Temporal trend in incidental prostate cancer detection at surgery for benign prostatic hyperplasia. Urology. 2018;122:152–7. https://doi.org/10.1016/j.urology.2018.07.028.

    Article  PubMed  Google Scholar 

  28. Becker A, Placke A, Kluth L, Schwarz R, Isbarn H, Chun F, et al. Holmium laser enucleation of the prostate is safe in patients with prostate cancer and lower urinary tract symptoms – a retrospective feasibility study. J Endourol. 2014;28:355–41. https://doi.org/10.1089/end.2013.0432.

    Article  Google Scholar 

  29. Nunez R, Hurd KJ, Noble BN, Castle EP, Andrews PE, Humphreys MR. Incidental prostate cancer revisited: early outcomes after holmium laser enucleation of the prostate. Int J Urol. 2011;18:543–7. https://doi.org/10.1111/j.1442-2042.2011.02776.

    Article  PubMed  Google Scholar 

  30. Ryoo HS, Suh YS, Kim TH, Sung HH, Jeong J, Lee KS. Efficacy of holmium laser enucleation of the prostate based on patient preoperative characteristics. Int Neurourol J. 2015;19:278–85. https://doi.org/10.5213/inj.2015.19.4.278.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Jeong J, Lee HS, Cho WJ, Jung W, You HW, Kim TH, et al. Effect of detrusor overactivity on functional outcomes after holmium laser enucleation of the prostate in patients with benign prostatic obstruction. Urology. 2015;86:133–8. https://doi.org/10.1016/j.urology.2015.03.033.

    Article  PubMed  Google Scholar 

  32. Lomas DJ, Krambeck AE. Long-term efficacy of holmium laser enucleation of the prostate in patients with detrusor underactivity or acontractility. Urology. 2016;97:208–11. https://doi.org/10.1016/j.urology.2016.07.010.

    Article  PubMed  Google Scholar 

  33. Mitchell CR, Mynderse LA, Lightner DJ, Husmann DA, Krambeck AE. Efficacy of holmium laser enucleation of the prostate in patients with non-neurogenic impaired bladder contractility: results of a prospective trial. Urology. 2014;83:428–32. https://doi.org/10.1016/j.urology.2013.09.035.

    Article  PubMed  Google Scholar 

  34. Woo MJ, Ha YS, Lee JN, Kim BS, Kim HT, Kim TH, et al. Comparison of surgical outcomes between holmium laser enucleation and transurethral resection of the prostate in patients with detrusor underactivity. Int Neurourol J. 2017;21:46–52. https://doi.org/10.5213/inj.1732640.320.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Cho MC, Ha SB, Park J, Son H, Oh SJ, Kim SW, et al. Impact of detrusor underactivity on surgical outcomes of laser prostatectomy: comparison in serial 12-month follow-up outcomes between potassium-titanyl-phosphate photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP). Urology. 2016;91:158–66. https://doi.org/10.1016/j.urology.2015.11.052.

    Article  PubMed  Google Scholar 

  36. Marien T, Kadihasanoglu M, Tangpaitoon T, York N, Blackburne AT, Abdul-Muhsin H, et al. Outcomes of holmium laser enucleation of the prostate in the re-treatment setting. J Urol. 2017;197:1517–22. https://doi.org/10.1016/j.juro.2016.12.098.

    Article  PubMed  Google Scholar 

  37. McAdams S, Funk JT, Navetta AF, el Tayeb MM, Humphreys MR. Holmium laser enucleation of the prostate after prostatic urethral lift surgery: feasibility and technical considerations from a multi-institutional case series. J Endourol. 2017;31:774–9. https://doi.org/10.1089/end.2017.0224.

    Article  PubMed  Google Scholar 

  38. Lee YJ, Oh SA, Kim SH, Oh SJ. Patient satisfaction after holmium laser enucleation of the prostate (HoLEP): a prospective cohort study. PLoS One. 2017;12:e0182230. https://doi.org/10.1371/journal.pone.0182230.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. • Cho MC, Kim JK, Ha SB, Ku JH, Paick JS. Self-assessed goal achievement (SAGA) after holmium laser enucleation of the prostate (HoLEP): association with patients' postoperative satisfaction. PLoS One. 2018;13:e0203825. https://doi.org/10.1371/journal.pone.0203825 Patient satisfaction after HoLEP was correlated with improvement in their self-assessed goals as well as subjective parameters including AUA Symptom Score and QOL assessment.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Brunckhorst O, Ahmed K, Nehikhare O, Marra G, Challacombe B, Popert R. Evaluation of the learning curve for holmium laser enucleation of the prostate using multiple outcome measures. Urology. 2015;86:824–9. https://doi.org/10.1016/j.urology.2015.07.021.

    Article  PubMed  Google Scholar 

  41. Robert G, Cornu JN, Fourmarier M, Saussine C, Descazeaud A, Azzouzi AR, et al. Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int. 2016;117(3):495–9. https://doi.org/10.1111/bju.13124.

    Article  PubMed  Google Scholar 

  42. Elshal AM, Nabeeh H, Eldemerdash Y, Mekkawy R, Laymon M, El-Assmy A, et al. Prospective assessment of learning curve of holmium laser enucleation of the prostate for treatment of benign prostatic hyperplasia using a multidimensional approach. J Urol. 2017;197(4):1099–107. https://doi.org/10.1016/j.juro.2016.11.001.

    Article  PubMed  Google Scholar 

  43. • Kampantais S, Dimopoulos P, Tasleem A, Acher P, Gordon K, Young A. Assessing the learning curve of holmium laser enucleation of prostate (HoLEP). A systematic review. Urology. 2018;120:9–22. https://doi.org/10.1016/j.urology.2018.06.012 This systematic review investigated the learning curve of HoLEP, which is approximately 25-50 cases.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kerri L. Thurmon.

Ethics declarations

Conflict of Interest

Bristol B. Whiles, Tomas L. Griebling, and Kerri L. Thurmon declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Urology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Whiles, B.B., Griebling, T.L. & Thurmon, K.L. Holmium Laser Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: a Safe and Effective Treatment Option in our Elderly Patients. Curr Geri Rep 8, 123–129 (2019). https://doi.org/10.1007/s13670-019-0281-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13670-019-0281-5

Keywords

Navigation